Wikidata

(Q28085019)

English

Anti-tumor necrosis factor patent expiration and the risks of biocopies in clinical practice

scientific article

In more languages

Statements

instance of
review article
7 references
stated in
PubMed
retrieved
1 August 2019
stated in
PubMed
retrieved
20 November 2019
stated in
PubMed
retrieved
27 November 2019
stated in
PubMed
retrieved
15 August 2020
stated in
PubMed
retrieved
14 November 2020
stated in
PubMed
retrieved
1 February 2021
stated in
PubMed
retrieved
28 October 2022
title
Anti-tumor necrosis factor patent expiration and the risks of biocopies in clinical practice (English)
1 reference
stated in
PubMed
main subject
tumor necrosis factor
2 references
stated in
PubMed
retrieved
1 August 2019
stated in
PubMed
retrieved
1 February 2021
peptide
1 reference
stated in
PubMed
retrieved
20 November 2019
blood proteins
1 reference
stated in
PubMed
retrieved
27 November 2019
biosimilar
1 reference
stated in
PubMed
retrieved
15 August 2020
author name string
Morton Scheinberg
series ordinal
1
1 reference
stated in
Crossref
Gilberto Castañeda-Hernández
series ordinal
2
1 reference
stated in
Crossref
volume
16
1 reference
stated in
PubMed
issue
6
1 reference
stated in
PubMed
page(s)
501
1 reference
stated in
PubMed
cites work

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q28085019&oldid=2177477396"